EGFR and lung adenocarcinoma: SP-D has recently been shown to inhibit the proliferation, migration and invasion of A549 human lung adenocarcinoma cells by binding to N-glycans of epidermal growth factor receptor (EGFR) via its CRD region, and interfering with EGF signaling (15).